Cel Sci Corporation (CVM)

[Fosco1]

We need a few scientific voices to talk here, not just Geert and Dr Talor
There seem to be real proven benefit out there, with significance, and enough matter and data for articles and scientific community to have a look and talk.
In the same manner BP will move when their scientists assess this and once they compute chances of approval and expected sales
At this point it is premature to say anything
Good questions for Geert at ASM : Total responders, special markers, significance in this sub-group, number of patients in significant group,revised target population